Qinghai Spring Medicinal Resources Technology Co., Ltd.

600381.SS · SHH
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Market CapCN¥2,134CN¥4,530CN¥7,227CN¥4,949
- CashCN¥207CN¥172CN¥169CN¥165
+ DebtCN¥12CN¥19CN¥5CN¥1
Enterprise ValueCN¥1,938CN¥4,377CN¥7,063CN¥4,785
RevenueCN¥270CN¥214CN¥160CN¥128
% Growth26.4%33.5%25.4%
Gross ProfitCN¥74CN¥129CN¥74CN¥25
% Margin27.2%60.4%46.1%19.7%
EBITDA-CN¥171-CN¥232-CN¥167-CN¥179
% Margin-63.2%-108.4%-104.3%-140%
Net Income-CN¥199-CN¥268-CN¥288-CN¥249
% Margin-73.5%-125.2%-179.5%-194.6%
EPS Diluted-0.34-0.46-0.49-0.42
% Growth26.1%6.1%-16.7%
Operating Cash FlowCN¥81CN¥24-CN¥32-CN¥64
Capital Expenditures-CN¥5-CN¥14-CN¥1-CN¥122
Free Cash FlowCN¥76CN¥10-CN¥33-CN¥186
Qinghai Spring Medicinal Resources Technology Co., Ltd. (600381.SS) Financial Statements & Key Stats | AlphaPilot